Özgür Kılıç

Özgür Kılıç

Auto-generated profile, based on publicly available information

Özgür Kılıç

Ondokuz Mayis University Faculty of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
YGYucel Gultekin
Yucel Gultekin
OKOzgur Kilic
Ozgur Kilic
ZOZerrin Ozcelik
Zerrin Ozcelik
STSukru Salih Toprak
Sukru Salih Toprak
RBRecep Bayram
Recep Bayram
OAOguzhan Arun
Oguzhan Arun
Cross-sectional area,gastric volume,ultrasonography

24 May 2021 in Turkish Journal of Colorectal Disease
Verified
Journal Article
Closed access
ÖKÖzgür Kılıç
Özgür Kılıç
YGYücel Gültekin
Yücel Gültekin
IBİsmail Biri
İsmail Biri
AYAhmet Uğur Yılmaz
Ahmet Uğur Yılmaz

6 January 2022 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Open access
GSGöktuğ Savaş
Göktuğ Savaş
SYSelçuk Yazıcı
Selçuk Yazıcı
ÖKÖzgür Kılıç
Özgür Kılıç
STSait Terzi
Sait Terzi
An 81-year-old man who had dyspnea was admitted to our hospital with a diagnosis of severe aortic stenosis. A transcatheter aortic valve implantation was successfully performed with a 29 mm Edwards Sapien XT valve using a transfemoral access. After the procedure, the echocardiography showed a restrictive ventricular septal defect (VSD) in the membranous septum. As the patient had no symptoms, it was decided to follow him up conservatively. However, he was readmitted within three weeks with symptoms suggestive of biventricular failure. A control echocardiography revealed a membranous VSD, 8 mm in size, right chambers dilatation with moderate tricuspid regurgitation, and systolic pulmonary artery pressure of 60 mm Hg. The previously deployed aortic valve was normal in function. The decision to perform a percutaneous VSD closure was made. The defect was then closed with a 10 mm muscular VSD occluder. During and after the procedure, there was no dysfunction in the bioprosthetic aortic valve. At the one-year follow-up, the patient was still asymptomatic.

24 May 2024 in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
ÖKÖzgür Kılıç
Özgür Kılıç
EKEbru Kulucan
Ebru Kulucan
YGYusuf Taha Güllü
Yusuf Taha Güllü
MPMehmet Polat
Mehmet Polat
MEM Elmali
M Elmali
MDMelda Dilek
Melda Dilek
Objective: Efficacy of high flow nasal oxygen (HFNO) use in COVID-19 patients who developed ARDS in medical wards is poorly studied. We aimed to investigate whether use of HFNO in wards outside intensive care unit under supervision of non-intensivists has clinical effects on acute respiratory failure and whether it reduces ICU workload. Methods: COVID 19 patients who received HFNO therapy for ARDS in medical wards of an academic hospital were analyzed retrospectively. Primary outcome was the proportion of patients who were successfully weaned from HFNO. Results: 43 patients ( 32 male, median age 61 [54-70] years) were investigated. 14 (33 %) patients weaned from HFNO and 29 (67%) patients failed HFNO and were tranferred to ICU. HFNO was applied in the group of HFNO with success with a median duration of 7 days (4-9) and in the failed group with median 3 days (2-5), p=0.002. Median SpO2 after HFNO was higher in patients with HFNO success compared to with HFNO failure [95 (94-97) vs 93 (92-95), p=0.015]. In the group of HFNO with success, there were more hypocapnic patients than in the group of HFNO with failure [19/29 (66 %) vs 3/14 (21%); p=0.015]. Logistic regression analysis indicated that patients with hypocapnia had 9.8 times the odds of having HFNO failure compared with patients with normocapnia.No patient died among the patients succeded HFNO however 90% of patients who transferred to ICU died. Conclusion: Use of HFNO for COVID-19 patients with ARDS at a non-critical setting seemed to be beneficial in avoiding intubation and reducing workload of ICU. However due to high mortality rate among the HFNO failed group, it would be better to be used undersupervision of intensivists and by skilled team.

12 February 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
SYSüleyman Yildirim
Süleyman Yildirim
NÖNurhayat Kilinç Özgün
Nurhayat Kilinç Özgün
ÖAÖzcan Alpdoğan
Özcan Alpdoğan
HUHüseyin Uçar
Hüseyin Uçar
ITİmRen Taşkiran
İmRen Taşkiran
CKCenk Kirakli
Cenk Kirakli
Background/aim: Invasive mechanical ventilation (IMV) is a fundamental intervention for patients with respiratory failure in intensive care units (ICUs). This nationwide, multicenter point-prevalence study aimed to describe current mechanical ventilation mode preferences (conventional, adaptive, and biphasic) in Turkish ICUs and to report associated clinical outcomes descriptively, without assessing causal relationships. Materials and methods: A nationwide, multicenter point-prevalence study was conducted on 17 April 2024 and included adult patients (≥18 years) who had been receiving IMV for more than 24 h. Data on patient demographics, ventilation mode distribution, ventilatory parameters, and descriptive clinical outcomes on day 28 (weaning status, tracheostomy, and mortality) were recorded without comparative outcome analysis. Results: A total of 426 patients were included. Conventional modes were used in 84.5% of patients, adaptive modes in 10.6%, and biphasic modes in 4.9%. Synchronized intermittent mandatory ventilation (SIMV) was the most commonly used conventional mode. The primary indication for IMV was acute respiratory failure (61%), with pneumonia being the leading cause. Among the 350 orotracheally intubated patients, 25.6% were in the weaning phase on the study day. A total of 59 (16.9%) patients were extubated, 150 (42.9%) underwent tracheostomy, and 64 (18.2%) remained intubated on day 28. Overall, 185 (43.4%) patients died during their ICU stay, 152 (35.7%) remained in the ICU, and 89 (20.9%) were successfully discharged from the ICU. Conclusion: Conventional ventilation modes, particularly SIMV, were more commonly used in Turkish intensive care units (ICUs), whereas adaptive modes were less frequently applied. These patterns may reflect factors such as clinician familiarity, institutional practices, and equipment availability rather than definitive preferences. Although the impact of ventilation modes on clinical outcomes was not comparatively evaluated in this study, the choice of ventilation mode may still influence patient outcomes. Therefore, further prospective and comparative studies are warranted to better elucidate this relationship.

30 January 2024
Verified
Preprint
Open access
ÖKÖzgür Kılıç
Özgür Kılıç
MPMehmet Polat
Mehmet Polat
EKEda Kopru
Eda Kopru
MEMuzaffer Elmali
Muzaffer Elmali
NTNazmiye Tibel Tuna
Nazmiye Tibel Tuna
MDMelda Dilek
Melda Dilek
Background: COVID 19 affects pregnant women more severe than the nonpregnant women of reproductive age. However, the rate of critical illness and fatality reported from the other studies varied in a wide range in both group. The study aims to investigate the clinical outcomes of pregnant and nonpregnant patients hospitalised with COVID 19 infection. Method: Clinical, radiologoic and laboratory data of pregnant and nonpregnant patients of reproductive age (18-45 years) infected with COVID 19 were analysed retrospectively. Results: Of 153 patients, 123 were nonpregnant and 30 were pregnant. 15 of the 30 pregnant patients delivered during the hopital stay and 6 of them received an urgent cesarean section. Of the six urgent delivery, five were due to respiratory insufficiency related to COVID 19 and one was unrelated to COVID 19. Four preterm birth, one perinatal death but no stillbirth or miscarriage was recorded. The most common symptom and comorbidity were cough and asthma in both group respectively. Semiquantative CT severity score was significantly higher in pregnants than in nonpregnants (9 points vs 2 points, p=0.022). Prognostic laboratory markers including lymphocytopenia, C-reactive protein and D-dimer were markedly worse in the pregnant group. Severe or critical patients were proportionally higher in the pregnants than in the nonpregnants (26% vs 15%, p=0.004). Hospital length of stay (HLOS) was median 4 vs 5 day; p=0.68, mortality rate was 1/123(0.8%) vs 0/30(0%), p=0.62; intensive care unit (ICU) admission rate was 3/123 (2.4%) vs 7/30 (23.3), p<0.001; need for invasive mechanical ventilation (IMV) was 2/123 (1.6%) vs 5/30 (17%), p=0.003 in nonpregnant and pregnant patients respectively. Conclusion: COVID 19 has a more severe course in pregnant women versus nonpregnant control group, but no difference was noted in terms of hospital length of stay and mortality.